| Rheumatoid Arthritis |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Thromboembolism |
0 |
0.65 |
| Hospital |
0 |
0.62 |
| Revenue and Practice Management |
0 |
0.45 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.41 |
| Lipids Management |
0 |
0.4 |
| California |
0 |
0.28 |
| Fellowship |
0 |
0.28 |
| Hypertension |
0 |
0.27 |
| Arthritis |
0 |
0.21 |
| Brachial |
0 |
0.21 |
| Cancer |
0 |
0.21 |
| Cardiovascular Imaging |
0 |
0.21 |
| Cerebrovascular Accident |
0 |
0.21 |
| Juvenile Rheumatoid Arthritis (JRA) |
0 |
0.19 |
| Osteoarthritis |
0 |
0.18 |
| CT Angiography |
0 |
0.17 |
| Psoriatic Arthritis |
0 |
0.16 |
| Pulmonary Embolism |
0 |
0.15 |
| Aspirin |
0 |
0.14 |
| CT Scan |
0 |
0.14 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Venous Thromboembolism (VTE) |
0 |
0.14 |
| Angina Pectoris |
0 |
0.1 |
| Health Care Reform |
0 |
0.09 |
| Ulcerative Colitis |
0 |
0.08 |
| Angiography |
0 |
0.07 |
| Artery |
0 |
0.07 |
| Body Mass Index |
0 |
0.07 |
| Calcium |
0 |
0.07 |
| Clinician Health and Well-Being |
0 |
0.07 |
| Colitis |
0 |
0.07 |
| Corticosteroids |
0 |
0.07 |
| Embolism |
0 |
0.07 |
| Heart |
0 |
0.07 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.07 |
| Hormone Replacement Therapy |
0 |
0.07 |
| Insurance |
0 |
0.07 |
| Medicare |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |
| Smoking |
0 |
0.07 |
| Stable Angina |
0 |
0.07 |
| Statins |
0 |
0.07 |
| Tumor |
0 |
0.07 |
| Inflammatory Bowel Disease |
0 |
0.06 |
| Medical Life |
0 |
0.06 |
| Menopause |
0 |
0.06 |
| Tobacco Cessation |
0 |
0.06 |